These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19429551)

  • 1. Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
    Böttiger T; Schneider T; Martínez B; Sahl HG; Wiedemann I
    Appl Environ Microbiol; 2009 Jul; 75(13):4427-34. PubMed ID: 19429551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
    Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
    Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
    Hsu ST; Breukink E; Bierbaum G; Sahl HG; de Kruijff B; Kaptein R; van Nuland NA; Bonvin AM
    J Biol Chem; 2003 Apr; 278(15):13110-7. PubMed ID: 12562773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
    Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
    Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
    Brötz H; Bierbaum G; Reynolds PE; Sahl HG
    Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding role of lipid II as a target for lantibiotics.
    Martin NI; Breukink E
    Future Microbiol; 2007 Oct; 2(5):513-25. PubMed ID: 17927474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
    Islam MR; Nishie M; Nagao J; Zendo T; Keller S; Nakayama J; Kohda D; Sahl HG; Sonomoto K
    J Am Chem Soc; 2012 Feb; 134(8):3687-90. PubMed ID: 22329487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
    Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
    Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.
    Wenzel M; Kohl B; Münch D; Raatschen N; Albada HB; Hamoen L; Metzler-Nolte N; Sahl HG; Bandow JE
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5749-57. PubMed ID: 22926563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lesson in efficient killing from two-component lantibiotics.
    Breukink E
    Mol Microbiol; 2006 Jul; 61(2):271-3. PubMed ID: 16771845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid II as a target for antibiotics.
    Breukink E; de Kruijff B
    Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
    Bonelli RR; Schneider T; Sahl HG; Wiedemann I
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Binding of the α-Component of the Lantibiotic Lichenicidin to the Peptidoglycan Precursor Lipid II Predetermines Its Antimicrobial Activity.
    Panina IS; Balandin SV; Tsarev AV; Chugunov AO; Tagaev AA; Finkina EI; Antoshina DV; Sheremeteva EV; Paramonov AS; Rickmeyer J; Bierbaum G; Efremov RG; Shenkarev ZO; Ovchinnikova TV
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
    Tol MB; Morales Angeles D; Scheffers DJ
    Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria.
    Héchard Y; Sahl HG
    Biochimie; 2002; 84(5-6):545-57. PubMed ID: 12423799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.
    Paiva AD; Breukink E; Mantovani HC
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5284-93. PubMed ID: 21876041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus.
    Sass P; Jansen A; Szekat C; Sass V; Sahl HG; Bierbaum G
    BMC Microbiol; 2008 Oct; 8():186. PubMed ID: 18947397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.